Intra-abdominal desmoplastic small round cell tumor: Immunohistochemical evidence for up-regulation of autocrine and paracrine growth factors

Citation
K. Froberg et al., Intra-abdominal desmoplastic small round cell tumor: Immunohistochemical evidence for up-regulation of autocrine and paracrine growth factors, ANN CLIN L, 29(1), 1999, pp. 78-85
Citations number
28
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF CLINICAL AND LABORATORY SCIENCE
ISSN journal
00917370 → ACNP
Volume
29
Issue
1
Year of publication
1999
Pages
78 - 85
Database
ISI
SICI code
0091-7370(199901/03)29:1<78:IDSRCT>2.0.ZU;2-I
Abstract
Desmoplastic small round cell turners (DSRCT) are highly aggressive tumors typically involving the serosal surfaces of the peritoneum. Patients often present with abdominal pain, an abdominal mass, ascites or signs of intesti nal obstruction. Cytogenetic and molecular studies have identified a charac teristic t(11;22)(p13;q12) translocation within the tumor cells. The fused gene product apparently aligns the NH2-terminal domain (NTD) of the EWS gen e to the zinc finger DNA-binding domain of the WT1 gene. This product could lead to loss of the tumor suppressor effect of the WT1 gene as well as to an increase in EWS driven expression of growth factors normally repressed b y WT1. We investigated this latter possibility by performing immunohistoche mical studies on formalin fixed tissue from 10 cases of DSRCT and five Wilm s' tumors using antibodies to insulin-like growth factor (IGF)-II, the late ncy associated peptide of transforming growth factor (TGF)-beta(1), platele t-derived growth factor (PDGF)-AB chain and PDGF-alpha receptor, respective ly. In general, tumor cells were strongly positive for these growth factors in DSRCT, while stromal cells were negative for IGF-II and positive for th e other growth factors in parallel with the tumor cells. Wilms' tumor cells were essentially negative for PDGF-AB chains, hut positive for ICF-II, and the latency associated peptide of TGF-beta(1) and variably positive for PD GF-alpha receptor. These findings support the proposed molecular mechanism of tumorigenesis for DSRCT and may help explain this tumor's poor prognosis .